Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Procaps Group SA banner

Procaps Group SA
NASDAQ:PROC

Watchlist Manager
Procaps Group SA Logo
Procaps Group SA
NASDAQ:PROC
Watchlist
Price: 1.1 USD Market Closed
Market Cap: $124.1m
Write Note Create Alert Ask AI

Bankruptcy Probability

Procaps Group SA's probability of bankruptcy is hidden . The solvency score is hidden .

We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.

Bankruptcy Probability
HIDDEN
Show

Financial Position

Cash & ST Investments
+
Sep 30, 2023 25.8m
Jun 30, 2023 19.9m
Mar 31, 2023 23m
Dec 31, 2022 43m
Long-Term Investments
+
Sep 30, 2023 6.2m
Jun 30, 2023 8.2m
Mar 31, 2023 1.9m
Dec 31, 2022 1.7m
Debt
+
Sep 30, 2023 220.7m
Jun 30, 2023 170m
Mar 31, 2023 150m
Dec 31, 2022 28.4m

Solvency Ratios

Solvency Ratios Comparison
Procaps Group SA Competitors

Country Company Market Cap D/E D/A Interest
Coverage 		Altman
Z-Score 		Quick
Ratio 		Current
Ratio 		Cash
Ratio
LU
Procaps Group SA
NASDAQ:PROC
124.1m USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
281.1B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
303.5B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
230.9B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.1B GBP
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.7B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found

See Also

Summary
PROC intrinsic value, competitors valuation, and company profile.
DCF Valuation
PROC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PROC stock valuation using valuation multiples.
Wall Street Estimates
PROC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PROC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Is Procaps Group SA at risk of bankruptcy?

Procaps Group SA's probability of bankruptcy is hidden .

The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Procaps Group SA have?

As of the latest report, Procaps Group SA has total debt of 220.7m USD. This includes both short-term (0 USD) and long-term (220.7m USD) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.